Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 1
2000 1
2002 1
2004 1
2006 2
2012 1
2015 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Histopathologic features of genetically determined ovarian cancer.
Shaw PA, McLaughlin JR, Zweemer RP, Narod SA, Risch H, Verheijen RH, Ryan A, Menko FH, Kenemans P, Jacobs IJ. Shaw PA, et al. Int J Gynecol Pathol. 2002 Oct;21(4):407-11. doi: 10.1097/00004347-200210000-00011. Int J Gynecol Pathol. 2002. PMID: 12352190
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update.
Gronwald J, Tung N, Foulkes WD, Offit K, Gershoni R, Daly M, Kim-Sing C, Olsson H, Ainsworth P, Eisen A, Saal H, Friedman E, Olopade O, Osborne M, Weitzel J, Lynch H, Ghadirian P, Lubinski J, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group. Gronwald J, et al. Int J Cancer. 2006 May 1;118(9):2281-4. doi: 10.1002/ijc.21536. Int J Cancer. 2006. PMID: 16331614 Free article.
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
Finch A, Beiner M, Lubinski J, Lynch HT, Moller P, Rosen B, Murphy J, Ghadirian P, Friedman E, Foulkes WD, Kim-Sing C, Wagner T, Tung N, Couch F, Stoppa-Lyonnet D, Ainsworth P, Daly M, Pasini B, Gershoni-Baruch R, Eng C, Olopade OI, McLennan J, Karlan B, Weitzel J, Sun P, Narod SA; Hereditary Ovarian Cancer Clinical Study Group. Finch A, et al. JAMA. 2006 Jul 12;296(2):185-92. doi: 10.1001/jama.296.2.185. JAMA. 2006. PMID: 16835424 Free article.
Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2.
Jernström H, Lerman C, Ghadirian P, Lynch HT, Weber B, Garber J, Daly M, Olopade OI, Foulkes WD, Warner E, Brunet JS, Narod SA. Jernström H, et al. Lancet. 1999 Nov 27;354(9193):1846-50. doi: 10.1016/s0140-6736(99)04336-6. Lancet. 1999. PMID: 10584720 Free article.
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.
Narod SA, Brunet JS, Ghadirian P, Robson M, Heimdal K, Neuhausen SL, Stoppa-Lyonnet D, Lerman C, Pasini B, de los Rios P, Weber B, Lynch H; Hereditary Breast Cancer Clinical Study Group. Narod SA, et al. Lancet. 2000 Dec 2;356(9245):1876-81. doi: 10.1016/s0140-6736(00)03258-x. Lancet. 2000. PMID: 11130383
Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Jernström H, Lubinski J, Lynch HT, Ghadirian P, Neuhausen S, Isaacs C, Weber BL, Horsman D, Rosen B, Foulkes WD, Friedman E, Gershoni-Baruch R, Ainsworth P, Daly M, Garber J, Olsson H, Sun P, Narod SA. Jernström H, et al. J Natl Cancer Inst. 2004 Jul 21;96(14):1094-8. doi: 10.1093/jnci/djh211. J Natl Cancer Inst. 2004. PMID: 15265971
ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium.
Poole EM, Gates MA, High BA, Chanock SJ, Cramer DW, Cunningham JM, Fridley BL, Gayther SA, Goode EL, Iversen ES, Lissowska J, Palmieri Weber RT, Pharoah PD, Phelan CM, Ramus SJ, Schildkraut JM, Sutphen R, Tsai YY, Tyrer J, Vierkant RA, Wentzensen N, Yang HP, Terry KL, Tworoger SS. Poole EM, et al. Cancer Causes Control. 2012 Nov;23(11):1805-10. doi: 10.1007/s10552-012-0059-y. Epub 2012 Sep 8. Cancer Causes Control. 2012. PMID: 22961099 Free PMC article.
A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer.
Richards EJ, Permuth-Wey J, Li Y, Chen YA, Coppola D, Reid BM, Lin HY, Teer JK, Berchuck A, Birrer MJ, Lawrenson K, Monteiro AN, Schildkraut JM, Goode EL, Gayther SA, Sellers TA, Cheng JQ. Richards EJ, et al. Oncotarget. 2015 Oct 27;6(33):34745-57. doi: 10.18632/oncotarget.5784. Oncotarget. 2015. PMID: 26430965 Free PMC article.